Vaccines and Biotechnology City

Vaccines and Biotechnology City is an Egypt-based biopharmaceutical vaccine manufacturer and national public-private initiative focused on localizing the development and production of human and veterinary vaccines. The company positions itself as a regional hub for vaccine innovation, technology transfer, and biomanufacturing serving Egypt, Africa, and the Middle East. Its first prominently disclosed product program is PCV13, and the company emphasizes health security, self-sufficiency, and export capacity alongside broader vaccine and biotechnology capabilities. VBC also operates with founding and strategic partners including MEVAC, UVAC, KEMIN, and Egypt’s National Service Projects Organization.